Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21328265rdf:typepubmed:Citationlld:pubmed
pubmed-article:21328265lifeskim:mentionsumls-concept:C1516213lld:lifeskim
pubmed-article:21328265lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:21328265lifeskim:mentionsumls-concept:C0040113lld:lifeskim
pubmed-article:21328265lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:21328265pubmed:issue2lld:pubmed
pubmed-article:21328265pubmed:dateCreated2011-2-17lld:pubmed
pubmed-article:21328265pubmed:abstractTextPurified thymus extracts (pTE) and synthetic thymic peptides (sTP) are thought to enhance the immune system of cancer patients in order to fight the growth of tumour cells and to resist infections due to immunosuppression induced by the disease and antineoplastic therapy.lld:pubmed
pubmed-article:21328265pubmed:languageenglld:pubmed
pubmed-article:21328265pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21328265pubmed:citationSubsetIMlld:pubmed
pubmed-article:21328265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21328265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21328265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21328265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21328265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21328265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21328265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21328265pubmed:statusMEDLINElld:pubmed
pubmed-article:21328265pubmed:issn1469-493Xlld:pubmed
pubmed-article:21328265pubmed:authorpubmed-author:ZwahlenMarcel...lld:pubmed
pubmed-article:21328265pubmed:authorpubmed-author:MilazzoStefan...lld:pubmed
pubmed-article:21328265pubmed:authorpubmed-author:HorneberMarku...lld:pubmed
pubmed-article:21328265pubmed:authorpubmed-author:WolfElkeElld:pubmed
pubmed-article:21328265pubmed:authorpubmed-author:BoehmKatjaKlld:pubmed
pubmed-article:21328265pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21328265pubmed:ownerNLMlld:pubmed
pubmed-article:21328265pubmed:authorsCompleteYlld:pubmed
pubmed-article:21328265pubmed:paginationCD003993lld:pubmed
pubmed-article:21328265pubmed:dateRevised2011-6-16lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:meshHeadingpubmed-meshheading:21328265...lld:pubmed
pubmed-article:21328265pubmed:year2011lld:pubmed
pubmed-article:21328265pubmed:articleTitleThymic peptides for treatment of cancer patients.lld:pubmed
pubmed-article:21328265pubmed:affiliationMedizinische Klinik 5-Schwerpunkt Onkologie/Haematologie, Klinikum Nord, Prof.-Ernst-Nathan-Str. 1, Nuernberg, Germany, D-90419.lld:pubmed
pubmed-article:21328265pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21328265pubmed:publicationTypeReviewlld:pubmed
pubmed-article:21328265pubmed:publicationTypeMeta-Analysislld:pubmed